Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2006 4
2007 2
2008 1
2009 1
2010 3
2011 3
2012 1
2013 8
2014 3
2015 5
2016 6
2017 2
2018 1
2019 4
2020 7
2021 10
2022 13
Text availability
Article attribute
Article type
Publication date

Search Results

69 results
Results by year
Filters applied: . Clear all
Page 1
The mechanisms of pharmacokinetic food-drug interactions - A perspective from the UNGAP group.
Koziolek M, Alcaro S, Augustijns P, Basit AW, Grimm M, Hens B, Hoad CL, Jedamzik P, Madla CM, Maliepaard M, Marciani L, Maruca A, Parrott N, Pávek P, Porter CJH, Reppas C, van Riet-Nales D, Rubbens J, Statelova M, Trevaskis NL, Valentová K, Vertzoni M, Čepo DV, Corsetti M. Koziolek M, et al. Among authors: trevaskis nl. Eur J Pharm Sci. 2019 Jun 15;134:31-59. doi: 10.1016/j.ejps.2019.04.003. Epub 2019 Apr 8. Eur J Pharm Sci. 2019. PMID: 30974173 Free article. Review.
Mesenteric lymphatic dysfunction promotes insulin resistance and represents a potential treatment target in obesity.
Cao E, Watt MJ, Nowell CJ, Quach T, Simpson JS, De Melo Ferreira V, Agarwal S, Chu H, Srivastava A, Anderson D, Gracia G, Lam A, Segal G, Hong J, Hu L, Phang KL, Escott ABJ, Windsor JA, Phillips ARJ, Creek DJ, Harvey NL, Porter CJH, Trevaskis NL. Cao E, et al. Among authors: trevaskis nl. Nat Metab. 2021 Sep;3(9):1175-1188. doi: 10.1038/s42255-021-00457-w. Epub 2021 Sep 20. Nat Metab. 2021. PMID: 34545251
Methods for studying pulmonary lymphatics.
Maldonado-Zimbron VE, Hong J, Russell P, Trevaskis NL, Windsor JA, Phillips ARJ. Maldonado-Zimbron VE, et al. Among authors: trevaskis nl. Eur Respir J. 2021 May 20;57(5):2004106. doi: 10.1183/13993003.04106-2020. Print 2021 May. Eur Respir J. 2021. PMID: 33863740 Free article. No abstract available.
Recent advances in lipid-based formulation technology.
Porter CJ, Williams HD, Trevaskis NL. Porter CJ, et al. Among authors: trevaskis nl. Pharm Res. 2013 Dec;30(12):2971-5. doi: 10.1007/s11095-013-1229-7. Epub 2013 Oct 26. Pharm Res. 2013. PMID: 24158727 No abstract available.
Targeting immune cells within lymph nodes.
Porter CJH, Trevaskis NL. Porter CJH, et al. Among authors: trevaskis nl. Nat Nanotechnol. 2020 Jun;15(6):423-425. doi: 10.1038/s41565-020-0663-z. Nat Nanotechnol. 2020. PMID: 32523098 No abstract available.
Lymphatic targeting by albumin-hitchhiking: Applications and optimisation.
Abdallah M, Müllertz OO, Styles IK, Mörsdorf A, Quinn JF, Whittaker MR, Trevaskis NL. Abdallah M, et al. Among authors: trevaskis nl. J Control Release. 2020 Nov 10;327:117-128. doi: 10.1016/j.jconrel.2020.07.046. Epub 2020 Aug 6. J Control Release. 2020. PMID: 32771478 Review.
Impact of gastrointestinal tract variability on oral drug absorption and pharmacokinetics: An UNGAP review.
Vinarov Z, Abdallah M, Agundez JAG, Allegaert K, Basit AW, Braeckmans M, Ceulemans J, Corsetti M, Griffin BT, Grimm M, Keszthelyi D, Koziolek M, Madla CM, Matthys C, McCoubrey LE, Mitra A, Reppas C, Stappaerts J, Steenackers N, Trevaskis NL, Vanuytsel T, Vertzoni M, Weitschies W, Wilson C, Augustijns P. Vinarov Z, et al. Among authors: trevaskis nl. Eur J Pharm Sci. 2021 Jul 1;162:105812. doi: 10.1016/j.ejps.2021.105812. Epub 2021 Mar 20. Eur J Pharm Sci. 2021. PMID: 33753215 Free article. Review.
69 results